Kohjin Bio Co., Ltd. (TYO:177A)
Japan · Delayed Price · Currency is JPY 1,016.00
+15.00 (1.50%)
Jun 3, 2026, 3:30 PM JST
Kohjin Bio Market Cap
Kohjin Bio has a market cap or net worth of 5.19 billion as of June 3, 2026. Its market cap has decreased by -39.95% in one year.
Market Cap
5.19B
Enterprise Value
4.90B
Revenue
4.94B
Ranking
n/a
PE Ratio
20.69
Stock Price
1,016.00
Market Cap Chart
Since April 25, 2024, Kohjin Bio's market cap has decreased from 11.89B to 5.19B, a decrease of -56.31%. That is a compound annual growth rate of -32.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 3, 2026 | 5.19B | -31.77% |
| Dec 30, 2025 | 7.61B | -11.16% |
| Dec 30, 2024 | 8.57B | -27.92% |
| Apr 25, 2024 | 11.89B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| StemCell Institute | 6.83B |
| Kubota Pharmaceutical Holdings | 6.46B |
| Soiken Holdings | 6.38B |
| CellSource | 6.33B |
| Noile-Immune Biotech | 5.80B |
| TMS Co., Ltd. | 5.78B |
| Chiome Bioscience | 5.52B |
| PRISM BioLab Co.,LTD | 5.17B |